Загрузка...
Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis
BACKGROUND: In 2016, the global number of individuals living with dementia was 43.8 million, representing a 117% increase from 1990—mainly due to increases in aging and population growth. Up to 90% of individuals with dementia experience neuropsychiatric symptoms (NPS). However, the limitations of c...
Сохранить в:
| Опубликовано в: : | Can J Psychiatry |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7265608/ https://ncbi.nlm.nih.gov/pubmed/31835954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0706743719892717 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|